Skip to content

Management of liver enlargement {Hepatomegaly} with gudduchhyadi churna and rohitakadi vati

A clinico-comparative study of Rohitakadi vati and Gudduchhyadi churna in the management of Yakriddalyudar w.s.r. Hepatomegaly - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109162
Enrollment
45
Registered
2026-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

None listed

Sponsors

Govt auto dhanwantari ayurvedic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical signs and symptoms like abdominal fullness,loss of appetite,nausea,vomiting ,fatigue, etc...

Exclusion criteria

Exclusion criteria: Below 20 years,above 60 years,pregnant women and lactating mothers,secondary liver diseases,infectious diseases,recent blood transfusion,recent alcohol use,recent use of hepatotoxic medications,recent liver biopsy,severe mental illness,recent major surgery

Design outcomes

Primary

MeasureTime frame
To reduce classical sign and symptoms of yakriddalyudar, such as tenderness, bloating, loss of appetite, fatigue, and vomiting.Timepoint: The outcome will be assessed after 2 months.

Secondary

MeasureTime frame
Effective management of yakriddalyudar by relieving the symptoms such as tenderness, fatigue, vomiting, nausea, bloating, loss of appetite, along with improvement in overall liver function & patient well-being.Timepoint: After 2 months of study

Countries

India

Contacts

Public ContactDr Naresh jain

Govt auto dhanwantari ayurvedic medical college and hospital ujjain M.P.

nareshjainujn@gmail.com9826064756

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026